Metastatic Invasive Breast Cancer Recurrence Following Curative-Intent Therapy for Ductal Carcinoma In Situ

2011 ◽  
Vol 165 (2) ◽  
pp. 172
Author(s):  
F. Al Mushawah ◽  
A. Rastelli ◽  
T. Pluard ◽  
J.A. Margenthaler
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma In Situ ◽  
Invasive Breast Cancer ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Cancer Recurrence ◽  
Breast Cancer Recurrence ◽  
Curative Intent

scholarly journals Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer

2011 ◽  
Vol 130 (1) ◽  
pp. 165-173 ◽  
Author(s):  
Ying Liu ◽  
Maria Pérez ◽  
Mario Schootman ◽  
Rebecca L. Aft ◽  
William E. Gillanders ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma In Situ ◽  
Invasive Breast Cancer ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Fear Of Cancer

Risk Reduction Strategies for Ductal Carcinoma In Situ

2010 ◽  
Vol 8 (10) ◽  
pp. 1211-1217 ◽  
Author(s):  
Adam L. Cohen ◽  
John H. Ward
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma In Situ ◽  
Invasive Breast Cancer ◽  
Carcinoma In Situ ◽  
Randomized Trials ◽  
Ductal Carcinoma ◽  
Cancer Recurrence ◽  
Recurrence Risk ◽  
Reduction Strategies

Ductal carcinoma in situ (DCIS) is a premalignant condition that, if left untreated, may progress to invasive breast cancer. After lumpectomy, DCIS can recur, and about half of recurrences are invasive. In 4 randomized trials, radiation has been shown to decrease the local recurrence rate by about half, though it does not change survival. Based on the results of 3 randomized trials, tamoxifen probably decreases cancer recurrence by about 30%, particularly in young women. Low fat diets, weight loss, and physical activity decrease invasive breast cancer recurrence and may be recommended to certain women with DCIS. Prognostic factors include age, extent of DCIS, margin status, grade, and presence of necrosis, although how these affect adjuvant therapy is unclear. Research evaluating other drugs to reduce recurrence risk and on different ways of delivering radiation continues.

Sign in / Sign up

Export Citation Format

Share Document